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Tuberculosis patients with identical strains of Mycobac-
terium tuberculosis are described as clustered. Cluster size 
may depend on patient or strain characteristics. In a 7-year 
population-based study of tuberculosis in Karonga District, 
Malawi, clusters were defi ned by using IS6110 restriction 
fragment length polymorphism, excluding patterns with <5 
bands. Spoligotyping was used to compare strains with an 
international database. Among 682 clustered patients, clus-
ter size ranged from 2 to 37. Male patients, young adults, 
and town residents were over-represented in large clusters. 
Cluster size was not associated with HIV status or death 
from tuberculosis. Spoligotypes from 9 (90%) of 10 large 
cluster strains were identical or very similar (1 spacer differ-
ent) to common spoligotypes found elsewhere, compared 
with 37 (66%) of 56 of those from nonclustered patients (p = 
0.3). Large clusters were associated with factors likely to be 
related to social mixing, but spoligotypes of common strains 
in this setting were also common types elsewhere, consis-
tent with strain differences in transmissibility.
Molecular techniques, in particular restriction frag-ment length polymorphism (RFLP) based on the 
IS6110 insertion element, are used to defi ne clusters of iso-
lates of Mycobacterium tuberculosis with identical DNA 
fi ngerprints. Many studies have investigated risk factors 
for clustering, but relatively little is known about the de-
terminants of cluster size (1,2). The size of clusters could 
depend on factors favoring transmission or on differences 
in the strains themselves. M. tuberculosis strains found in 
persons with smear-positive disease, many contacts, or de-
lays in diagnosis and effective treatment are particularly 
likely to be transmitted. Some strains may be inherently 
more transmissible than others, perhaps because they are 
particularly likely to give rise to sputum smear–positive 
disease, they are associated with a more insidious onset of 
clinical symptoms (so patients are infectious for longer), or 
they are more virulent and are therefore more likely to give 
rise to secondary cases within the period studied (3). Large 
clusters may also be observed if the strain has a particularly 
stable RFLP pattern; this may be more likely for strains 
with few bands.
Epidemiologic differences can be explored by exam-
ining risk factors for cluster size. Giordano et al. (1) hy-
pothesized that cluster size would be related to duration 
of symptoms. Those researchers found no evidence of this 
but did fi nd inverse associations with age and HIV status 
in a population-based study in Texas in the United States. 
Strain-related differences are likely if the same strains give 
rise to large clusters in unrelated populations. The ubiquity 
of the Beijing family of strains has led to speculation that 
they may be particularly virulent or transmissible (4).
In a population-based study of the molecular epidemi-
ology of tuberculosis in northern Malawi, we found that 
clustering was associated with young age, female sex, area 
of residence, and, in older adults, HIV positivity (5). We 
explored the determinants of cluster size and the character-
istics of the larger clusters.
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Methods
As part of the Karonga Prevention Study, northern Ma-
lawi, all persons with suspected tuberculosis at peripheral 
clinics and the district hospital are seen by project staff. 
Sputum is collected for smear and culture; lymph node and 
pleural and peritoneal aspirates are also cultured, when 
available. Cultures are set up in the project laboratory in 
Malawi, and those macroscopically consistent with M. tu-
berculosis are sent to the Health Protection Agency My-
cobacterium Reference Unit, London, United Kingdom, 
for species identifi cation and drug resistance testing. HIV 
testing is conducted after counseling, if consent is given. 
Patients are treated for tuberculosis according to Malawi 
government guidelines (6).
DNA fi ngerprinting using IS6110 RFLP has been con-
ducted on isolates from patients who have been diagnosed 
since late 1995, following standard procedures (7). Patients 
whose disease was diagnosed up to early 2003 were includ-
ed in this analysis. RFLP patterns were compared by using 
computer-assisted (Gelcompar 4.1; Applied Maths, Ko-
rtrijk, Belgium) visual comparison. Laboratory error was 
thought likely if isolates with identical RFLP patterns were 
isolated on the same day from patients with no known epi-
demiologic relationship if, in addition, there was no other 
laboratory evidence of tuberculosis, or if they were the only 
2 examples of this RFLP pattern, or if the patients had other 
isolates with different patterns (8). After likely laboratory 
errors were excluded, RFLP patterns shared by >1 patient 
were classifi ed as clustered. Some patients had >1 isolate. 
To defi ne whether a strain was clustered and to determine 
the size of the cluster, patients were included more than 
once if they had >1 RFLP pattern. Thereafter, patients were 
only included once, for their fi rst episode of tuberculosis 
for which an RFLP result was available.
Spoligotyping (9) was performed on at least 2 iso-
lates of clusters containing at least 15 patients, to enable 
comparison of strains with international databases (10,11). 
Changes in the proportion of tuberculosis cases caused by 
each of these large cluster strains over time was examined, 
by using the Fisher exact test to compare proportions and 
the χ2 test for linear trend. Spoligotyping was also per-
formed on unique (not clustered) strains from patients with 
smear-positive tuberculosis in 1998 or 1999, as examples 
of strains that had apparently not spread in the population; 
and from all positive cultures from 2002. Previously identi-
fi ed spoligotypes were defi ned as widespread if the inter-
national database described them as both “ubiquitous” and 
“recurrent,” “common,” or “epidemic.”
Analysis of cluster size excluded unique strains and 
strains with <5 bands on the RFLP (because patterns with 
few bands are insuffi ciently discriminatory). Cluster size 
was divided into 4 groups (Table 1), and associations with 
cluster size were determined by using maximum-likelihood 
ordered logistic regression with the ologit command in 
STATA (12). With this method, the odds ratios calculated 
represent the summary relative odds of larger clusters com-
pared to smaller clusters across the 4 groups. This method 
was used in preference to linear regression because cluster 
size is not normally distributed, and in preference to lo-
gistic regression because it avoids arbitrary dichotomiza-
tion of cluster size. All available risk factors for cluster 
size were assessed individually (Table 1), and factors that 
were signifi cant at the 5% level, after adjusting for other 
factors, or that confounded other variables were retained 
in the fi nal model. The molecular epidemiologic work of 
the Karonga Prevention Study was approved by the Malawi 
National Health Sciences Research Committee and the eth-
ics committee of the London School of Hygiene and Tropi-
cal Medicine.
Results
Over the study period, 1,248 cases of culture-positive 
tuberculosis were diagnosed in patients in Karonga Dis-
trict. RFLP results were available on 1,194 isolates from 
1,044 patients. After we excluded 25 isolates because labo-
ratory error was suspected (8), there were results for 1,029 
patients. Eighty-one had <5 bands so they were excluded. 
Of the remaining 948 patients, 682 (72%) were clustered 
and form the basis of this analysis.
Cluster size varied from 2 to 37. The determinants of 
cluster size are shown in Table 1. Older patients were less 
likely than younger patients to be in large clusters. Male 
patients were more likely than female patients to be in large 
clusters, and there was variation by geographic area. Cluster 
size was not statistically associated with HIV status, type 
of tuberculosis, previous tuberculosis, or drug resistance. 
Patients in small clusters were as likely to die during treat-
ment as those in large clusters. In the multivariate analysis, 
the results were similar (Table 2), with signifi cant associa-
tions with age, sex, and area of residence. The results were 
unchanged by adjusting for year or for RFLP band number. 
None of the other factors shown in Table 1 was associated 
with clustering after we adjusted for possible confounders. 
Repeating the analysis with different categorizations of 
cluster size gave similar results (not shown).
All of the large cluster strains (>15 people) were found 
in at least 4 of the 6 geographic areas of the district, and 
most were found throughout the district. The distributions 
of the 4 largest clusters are shown in the Figure. Patients 
with strains from most of the large clusters were present 
in the district throughout the study period. Trends over 
time for strains involving at least 15 people are shown in 
Table 3. Only 1 strain, kps121, showed statistically signifi -
cant changes over time; it appeared to be decreasing.
Spoligotypes from large clusters (>15 people) were 
compared with the international database (10,11). The re-
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sults, displayed according to the octal code, are shown in 
Table 4 (13). Six of the large cluster strains had patterns 
identical or very similar to spoligotype 59, which is clas-
sifi ed as ubiquitous and recurrent (10,11). These 6 RFLP-
defi ned strains (kps10, 12, 20, 21, 41, and 64) had similar 
RFLP patterns, with a similarity coeffi cient of 79% (with 
1% position tolerance).
The spoligotypes for RFLP-defi ned strains kps104, 
kps44, and kps97 were also identical or similar to previous-
ly described widespread spoligotypes, types 21, 53, and 1 
(Beijing), respectively. The spoligotype for strain kps121, 
spoligotype129, was not similar to any widespread types.
The spoligotypes from the RFLP-defi ned large cluster 
strains were compared with spoligotypes from patients with 
positive cultures in 2002, and from patients with smear-
positive tuberculosis and unique RFLP patterns in 1998 
through 1999. Overall, 9 (90%) of 10 of the large cluster 
strains had spoligotypes that were identical to, or only 1 
spacer different from, previously described widespread 
spoligotypes. For the patients from 2002, this proportion 
was 90 (71%) of 126 (p = 0.3 when compared to the large 
cluster strains), and for the smear-positive unique strains, it 
was 37 (66%) of 56 (p = 0.3 compared to the large cluster 
strains).
All the spoligotypes that were found in the RFLP-de-
fi ned large cluster strains were also found among (RFLP-
defi ned) unique strains. Seventeen of the unique strains had 
spoligotype 59, and 2 others had closely related patterns (i.e., 
1 spacer different); 1 had spoligotype 21, and 1 had a closely 
related pattern; 4 had spoligotype 53, and 2 had closely re-
lated patterns; and 6 had spoligotype 129. Of the 56 patients 
from 1998 to 1999, none had Beijing spoligotypes, but we 
have previously described strains with Beijing spoligotypes 
and unique RFLP patterns in this population (14).
The spoligotypes found in the large cluster strains 
were also common among the unselected patients from 
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Table 1. Associations between patient characteristics and cluster size, Mycobacterium tuberculosis, bivariate analysis, Malawi 
Cluster size, %
Characteristic N
2–4
(n = 186)
5–10
(n = 196)
11–20
(n = 173)
>20
(n = 127)
Odds ratio
(95% CI)* p value 
Age, y 0.05
 <25 111 27.9 25.2 25.2 21.6 1
 25–34 266 24.4 26.3 27.8 21.4 1.1 (0.74–1.7) 
 35–44 160 26.3 32.5 25.0 16.3 0.87 (0.56–1.3) 
>45 145 33.1 31.7 21.4 13.8 0.66 (0.42–1.0) 
Sex 0.1
 F 386 27.2 30.3 26.9 15.0 1
 M 296 26.7 26.7 23.3 23.3 1.2 (0.95–1.6) 
HIV status 1.0
 Negative 141 26.2 30.5 23.4 19.9 1
 Positive 288 26.4 28.1 27.8 17.7 1.0 (0.7–1.4) 
Area 0.005
 South, near Chilumba 70 38.6 22.9 24.3 14.3 0.51 (0.31–0.84) 
 Middle, near Nyungwe 89 20.2 22.5 30.3 27.0 1.2 (0.79–1.9) 
 Around Karonga 119 25.2 34.5 21.9 18.5 0.73 (0.48–1.1) 
 Karonga central (urban) 209 21.5 25.4 32.5 20.6 1
 Kaporo area 84 35.7 34.5 15.5 14.3 0.46 (0.29–1.1) 
 Far north 57 28.1 40.4 21.1 10.5 0.54 (0.32–0.9) 
 Outside district 16 26.9 28.9 25.6 18.6 0.41 (0.61–1.1) 
Tuberculosis type 0.6
 Smear positive 485 26.2 29.5 25.4 19.0 1
 Smear negative 145 29.7 24.8 27.6 17.9 0.94 (0.68–1.3) 
 Extrapulmonary 52 30.8 32.7 19.2 17.3 0.78 (0.47–1.3) 
Previous tuberculosis 0.6
 No 628 27.4 28.8 25.8 18.0 1
 Yes 47 27.7 25.5 21.3 25.5 1.2 (0.68–2.0) 
Isoniazid resistance 0.2
 No 641 28.1 27.9 25.9 18.1 1
 Yes 39 12.8 43.6 15.4 28.2 1.5 (0.84–2.6) 
Died† 1.0
 No 382 26.7 28.3 25.1 19.9 1
 Yes 155 25.8 29.0 26.5 18.7 1.0 (0.72–1.4) 
*Odds ratio from ordered logistic regression. This represents the summary relative odds of larger clusters compared with smaller clusters across the 4 
groups. Odds ratios >1 imply that the odds of being in a larger cluster are greater than in the baseline group. CI, confidence interval. 
†Outcome recorded for 632 patients; those who were lost or transferred while receiving treatment are excluded from this analysis. 
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2002. Thirty-six (29%) had spoligotype 59, and 10 more 
had closely related patterns; 11 (9%) had spoligotype 21; 
8 (6%) had spoligotype 53, and 2 had closely related pat-
terns; 7 (6%) had the Beijing spoligotype; and 8 (6%) had 
spoligotype 129. The 36 isolates with spoligotype 59 had 
23 different RFLP patterns with a similarity coeffi cient 
of 63%.
Discussion
This study suggests that both epidemiologic and strain-
related factors may contribute to large cluster size. In large 
clusters young adults, male patients, and those living in the 
town were over-represented, all factors likely to be asso-
ciated with increased social mixing. Similar associations 
with age and sex have been found previously, in the United 
States and Denmark. In Denmark the largest cluster was 
particularly predominant in the capital city (1,2).
There was no signifi cant association between tuber-
culosis type (smear positive, smear-negative pulmonary, 
or extrapulmonary) and cluster size, but most patients 
had sputum smear–positive disease. There was also no 
statistically signifi cant association with degree of smear 
positivity (not shown). An overall association with infec-
tiousness would not necessarily be expected: the infec-
tiousness of the fi rst cases of a cluster may be important 
in determining size, but the fi rst cases for the large clus-
ters, which were found throughout the period of study, are 
not identifi able. There was no signifi cant association with 
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Table 2. Multivariate analysis of risk factors for larger cluster size, 
Malawi 
Cluster size*
Risk factor Odds ratio 95% CI p value 
Age, y
 <25 1 0.01†
 25–34 1.0 0.66–1.5
 35–44 0.76 0.48–1.2
>45 0.62 0.39–1.0
Male 1.4 1.0–1.8 0.03
Area <0.001
 South, near Chilumba 0.54 0.33–0.90
 Middle, near Nyungwe 1.3 0.81–2.0
 Around Karonga 0.74 0.50–1.1
 Karonga central (urban) 1
 Kaporo area 0.48 0.30–0.76
 Far north 0.55 0.32–0.92
 Outside district 0.41 0.15–1.1
*Odds ratios are adjusted for the other factors shown in the table (i.e., the 
multivariate equation contained age group, sex, and area). CI, confidence 
interval. 
†Trend.
Figure. Geographic distribution of the 4 
most common strains defi ned by restriction 
fragment length polymorphism: A) strain 
kps12, B) strain kps121, C) strain kps41, 
and D) strain kps44. Each o represents a 
patient. Each square is 10 km × 10 km. The 
background shading represents the total 
number of tuberculosis (TB) cases in each 
area during the study period, which largely 
refl ects the population density.
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isoniazid resistance, but only 39 (6%) patients had resis-
tant strains. Isoniazid resistance has been associated with 
reduced clustering and reduced generation of secondary 
cases (15,16) so it might have been expected to be less 
common in the larger clusters. Only 3 clustered patients 
had rifampin resistance in our study (2 with 1 strain and 
1 with another), so the effect of this factor on cluster size 
could not be investigated.
The factors associated with cluster size were not identi-
cal to those associated with clustering overall (5). Whereas 
younger adults were more likely to have clustered strains 
and to be in large clusters, female patients were more 
likely to have clustered strains but among clustered case-
patients, male patients were more likely to be in large clus-
ters. Known contact with a previous tuberculosis patient 
is an important risk factor for tuberculosis, especially for 
women in this population (17). It may be that women are 
particularly likely to become infected at home (and there-
fore be in small clusters) and that men are more likely to 
become infected outside the home, sometimes from outside 
the area (seen as unique strains) and sometimes as part of 
large clusters.
We found no evidence of an association of cluster size 
with HIV status, although we had previously found HIV 
to be associated with clustering among older patients (5). 
The effect of HIV infection on clustering is complex since 
it depends both on the biologic effects of HIV (increasing 
the risks for active disease—perhaps to different extents for 
primary and postprimary disease—and decreasing infec-
tiousness) and on any tendency for HIV and tuberculosis to 
affect the same subpopulations with shared risk factors.
Strain virulence was assessed by examining the pro-
portion of patients who died: there was no association with 
cluster size either overall, or separately, in HIV-positive or 
-negative patients (data not shown). Virulent strains could 
lead to large clusters if virulence were associated with in-
creased transmission rates or increased rates of disease af-
ter infection (3). However, virulent strains could have less 
opportunity to transmit if the severity of symptoms leads to 
early treatment or death, thus reducing the duration of the 
infectious period.
Evidence that strain characteristics may have contrib-
uted to cluster size comes from the fi nding that the spo-
ligotypes of most of the common RFLP-defi ned strains 
in this study were identical to, or only 1 spacer different 
from, widespread spoligotypes already described. Unique 
RFLP-defi ned strains from smear-positive patients in the 
early part of the study were used as a comparison group. 
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Table 3. Proportion of all tuberculosis cases caused by each of the RFLP-defined large cluster strains over time, Malawi* 
Tuberculosis cases caused by each strain, % (no.) 
Strain No. patients 1995–1997 1998–1999 2000–2001 2002–2003 p value 
Kps10 18 2.3 (6) 0.9 (3) 1.7 (5) 2.8 (4) 0.4
Kps12 34 1.5 (4) 3.9 (13) 4.9 (14) 2.1 (3) 0.1
Kps20 15 1.9 (5) 0.9 (3) 1.7 (5) 1.4 (2) 0.7
Kps21 15 0.8 (2) 2.1 (7) 2.1 (6) 0.0 (0) 0.2
Kps41 37 4.2 (11) 3.0 (10) 4.5 (13) 2.1 (3) 0.5
Kps44 29 3.8 (10) 3.3 (11) 1.4 (4) 2.8 (4) 0.3
Kps64 16 0.4 (1) 1.5 (5) 2.8 (8) 1.4 (2) 0.1
Kps97 15 0.8 (2) 2.4 (8) 1.0 (3) 0.7 (1) 0.3
Kps104 16 1.5 (4) 0.9 (3) 2.1 (6) 2.1 (3) 0.6
Kps121 27 4.2 (11) 2.7 (9) 2.1 (6) 0.7 (1) 0.03 (trend) 
*RFLP, restriction fragment length polymorphism. 
Table 4. Spoligotypes for the RFLP-defined large cluster strains with at least 5 bands* 
Strain no.
No. bands on 
RFLP
No. examples 
spoligotyped
Spoligotype octal 
description
International
classification Comment
Kps41 11 5 777777606060771 59 Widespread
Kps20 8 3 777777606060771 59 Widespread
Kps21 8 2 777777606060771 59 Widespread
Kps10 10 1 777777606060771 59 Widespread
1 777777206060771 Not recorded
Kps12 9 3 577777606060771 Not recorded
Kps64 9 2 777777606060771 59 Widespread
1 777437606060731 Not recorded
Kps121 13 2 700777747413771 129 3 recorded, Zimbabwe, 
French Guiana
Kps104 14 2 703377400001771 21 Widespread
1 703377400001631 Not recorded
Kps44 16 5 777777777760771 53 Widespread
Kps97 22 2 000000000003771 1 Widespread, Beijing
*RFLP, restriction fragment length polymorphism. 
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Smear-positive case-patients were chosen to maximize the 
likelihood of transmission occurring; early cases were used 
to allow time for secondary cases to have been identifi ed 
if they had occurred. These unique strains were less likely 
than the large cluster strains to have spoligotypes that were 
closely related to widespread types, but this difference was 
not statistically signifi cant, and the spoligotypes that were 
found in the large cluster strains were also found among 
the unique strains. Interestingly, strain kps121, which was 
the only large cluster strain with a spoligotype not closely 
related to a widespread previously described type, was also 
the 1 large cluster strain that was clearly decreasing in the 
Karonga population.
The fi nding of large cluster strains with previously 
described widespread spoligotypes may suggest that these 
strains are particularly transmissible or particularly likely 
to cause disease. Other possibilities are that they are older 
in evolutionary terms, and thus have had more time to be-
come widespread, or that we are seeing a founder effect 
in some populations with subsequent spread following hu-
man migration patterns. Spoligotype 59 was common in 
the Malawi population in all groups of patients, clustered 
and unique, and was associated with a wide diversity of 
RFLP patterns, which suggests that it may be a longstand-
ing strain in this area. It was also the most common spoli-
gotype found in studies in Zimbabwe and Zambia (18,19). 
However, spoligotype 59 was particularly common among 
the isolates from large clusters, with more closely related 
RFLP patterns, consistent with some variants having high 
transmissibility. Spoligotype 59 has been classifi ed as be-
longing to the Latin-American-Mediterranean lineage (18), 
and as part of the strain family Southern Africa Family 1 
(19). The large cluster strain kps97 had a Beijing spoligo-
type and in total, we have previously identifi ed 44 patients 
with Beijing strains in this dataset, with 12 different RFLP 
patterns (14). Beijing strains have been associated with in-
creased virulence and growth rates in vitro (20–22). That 
there are true differences in strain characteristics between 
other clustered and nonclustered strains is beginning to be 
established in in vitro studies from other populations (23).
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